Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.

Publications // Young Lab // Jan 01 2018

PubMed ID: 29865051

Author(s): Lupton MK, Medland SE, Gordon SD, Goncalves T, MacGregor S, Mackey DA, Young TL, Duffy DL, Visscher PM, Wray NR, Nyholt DR, Bain L, Ferreira MA, Henders AK, Wallace L, Montgomery GW, Wright MJ, Martin NG. Accuracy of inferred APOE genotypes for a range of genotyping arrays and imputation reference panels. J Alzheimers Dis. 2018;64(1):49-54. doi: 10.3233/JAD-171104. PMID 29865051

Journal: Journal Of Alzheimer’s Disease : Jad, Volume 64, Issue 1, 2018

Cohort studies investigating aging and dementia require APOE genotyping. We compared directly measured APOE genotypes to ‘hard-call’ genotypes derived from imputing genome-wide genotyping data from a range of platforms using several imputation panels. Older GWAS arrays imputed to 1000 Genomes Project (1KGP) phases and the Haplotype Reference Consortium (HRC) reference panels were able to achieve concordance rates of over 98% with stringent quality control (hard-call-threshold 0.8). However, this resulted in high levels of missingness (>12% with 1KGP and 5% with HRC). With recent GWAS arrays, concordance of 99% could be obtained with relatively lenient QC, resulting in no missingness.